In addition, immunization with flagellin expressing cancer cells lead to impressive antigen-specific CD4 and CD8 T cell responses via NLRC4 and NAIP5 signaling and bestowed anti-tumor immunity against a secondary inoculation with tumor cells (231). The gene discussed is NLRC4; the disease is neoplasm.